Wednesday, July 8, 2026

pharma · Nicotine use

SWEDISH ORPHAN BIOVITRUM

SWEDISH ORPHAN BIOVITRUM trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

IT HQ
3 Employees
TGA registrant Type
Company details
Status
Public
HQ
IT
Employees
3
Programs
2
Drugs
10
Patents
0
Intelligence · Clinical Trials

SWEDISH ORPHAN BIOVITRUM clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to SWEDISH ORPHAN BIOVITRUM programs — each row shows trial ID, program name, phase, status, and indication.

SWEDISH ORPHAN BIOVITRUM trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for SWEDISH ORPHAN BIOVITRUM.

  1. SM25-01 — Phase 1

    Clinical update
  2. NI-501; emapalumab, NI-501; emapalumab — Phase 3

    Clinical update

Trial registry

2 studies